Company page
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. is a publicly traded company listed under the ticker REGN on the American stock market. The company has a market capitalization of approximately $63.9 billion. Regeneron focuses on developing and commercializing innovative medicines for serious diseases.
- Ticker
- REGN:NASDAQ
- Asset type
- Stock
- Market cap
- $63.95B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD